Palleon Pharmaceuticals Inc. — Form D/A
Palleon Pharmaceuticals Inc. of WALTHAM, MA, a company, filed a Form D amendment with the SEC on 2017-11-17. The offering totals $48.3M, of which $20.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-11-17
- Form: D/A
- Accession: 0001678852-17-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $48.3M
- Amount sold: $20.6M
- Remaining: $27.7M
- Investors: 6
- Date of first sale: 2016-06-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-266476
Issuer
- Name: Palleon Pharmaceuticals Inc.
- CIK: 0001678852
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 266 SECOND AVENUE, 2ND FLOOR, WALTHAM, MA, 02451
- Phone: 857-285-5900
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Jens W Eckstein | Director | Waltham, MA |
| Karen W Hong | Director | Waltham, MA |
| James W Lee | Director | Waltham, MA |
| Karan W Takhar | Director | Waltham, MA |
| William W Burkoth | Director | Waltham, MA |
| Rajeev W Dadoo | Director | Waltham, MA |
| John W Hennessy | Executive Officer | Waltham, MA |
| Stephen W Hoffman | Director | Waltham, MA |
| Eric W Xiao | Director | Waltham, MA |
| James W Broderick | Director | Malvern, PA |
| James W Broderick | Executive Officer | Malvern, PA |
Other filings by this issuer (2)
More